GlassScriptPhysician profile
Anu Chakraborty
NPI 1811943541
$1,664.45
in general payments reported to CMS, 2019-2025
20 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $107 · 2021: $225 · 2022: $577 · 2023: $327 · 2024: $49.34 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $392 · Education: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $392.06 |
| Education | $145.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $276.95 | 2020-2023 | Liletta |
| Mayne Pharma Commercial LLC | $179.00 | 2021-2025 | |
| Lupin INC. | $172.60 | 2019-2021 | |
| Astellas Pharma US INC | $169.72 | 2019-2024 | Veozah |
| Avion Pharmaceuticals | $162.42 | 2019-2023 | Balcoltra |
| Heron Therapeutics, INC. | $125.00 | 2022 | |
| Evofem Biosciences, INC. | $115.72 | 2020-2023 | Phexxi |
| Sumitomo Pharma America, INC. | $81.28 | 2023-2024 | Myfembree |
| Baxter Healthcare | $68.15 | 2025 | |
| Millicent US INC | $66.75 | 2022-2023 | Femring |
| Therapeuticsmd, INC. | $53.39 | 2019-2020 | |
| Scynexis, INC. | $46.98 | 2022 | |
| Pfizer INC. | $46.38 | 2022-2023 | |
| Coopersurgical, INC. | $25.88 | 2021 | |
| Agile Therapeutics, INC. | $17.36 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $17.34 | 2023 | Slynd |
| Organon LLC | $14.45 | 2022 | |
| Merck Sharp & Dohme LLC | $12.71 | 2020 | |
| Allergan, INC. | $12.37 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anu Chakraborty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.